[1] 吴开良, 李艳如, 蒋国梁. 放射性肺损伤[J]. 实用肿瘤杂志, 2001,16(1):110. [2] 崔晓利, 刘海玲, 董秀月, 等. 转化生长因子pl表达在小鼠放射性肺纤维化形成过程中的作用[J]. 中华放射肿瘤学杂志, 1999,8(1):47. [3] 曹京旭, 张旭志. 细胞因子与放射性肺损伤[J]. 国外医学·放射医学核医学册, 2001,25(4):181. [4] Rubin P, Johnston C L, Williams J P, et al. A Perpetual Cascade of Cytok Ines Postirradiation Leads to Pulmonary Fibrosis[J]. International Journal of Radiation Oncology Biology Physics, 1995,33(1):99. [5] Anscher M S, Murase T, Prescott D M, et al. Changes in Plasma TGF-β Levels During Pulmonary Radiotherapy as a Predictor of the Risk of Developing Radiation Pneumonitis[J]. International Journal of Radiation OncologyBiology Physics, 1994,30(3):671. [6] 郭莉莉, 徐凯. 放射性肺损伤的研究进展[J]. 徐州医学院学报,2007,27(3):198. [7] Yildiz O G. Protective Effects of Caffeic Acid Phenethyl Ester on Radiation Induced Lung Injury in Rats[J]. Clinical and Investigative Medicine, 2008,31(5):242. [8] 白蕴红, 王德文, 徐在海, 等. 放射性间质性肺炎病变规律及其机理研究[J]. 解放军医学杂志, 1993,18(1):14. [9] Hareyama M, Satoh M, Yamagishi M, et al. Radiation Tolerance of Normal Lung-Pulmonary Radiation Syndrome[J]. Gan No Rinsho, 1990,36(13):2319. [10] 郑红, 金冶宁. 放射性肺损伤的研究进展[J]. 第二军医大学学报, 2002,11,23(11):1264. [11] 王丽, 冯炎. 放射性肺损伤的研究进展[J]. 中国肺癌杂志, 2004,7(5):462. [12] 夏丽天, 李而周, 李莹, 等. 胸部肿瘤放疗后引起放射性肺炎的相关因素及CT表现[J]. 实用放射学杂志, 2002,18(1):11. [13] 吕国庆, 吴恒, 张雨洁. II、III期乳腺瘟术后三种放疗方式对肺损伤的研究[J].吉林医学, 2010,3l(27):4661. [14] Vogelius I R, Westerly D C, Aznar M C, et a1. Estimated RadiationPneumonitis Risk After Photon Versus Proton Therapy Alone or Combined With Chemotherapy for Lung Cancer[J]. Acta Oncologica, 201l,50(6):772. [15] Ghosh S N, Zhang R, Fish B L, et a1. Renin-angiotensin System Suppression Mitigates Experimental Radiation Pneumonitis[J]. International Journal of Radiation Oncology Biology Physics, 2009,75(5):1528. [16] Colon J, Herrera L, Smith J, et a1. Protection From Radiation-Induced Pneumonitis using Cerium Oxide Nanoparticles[J]. Nanomedicine, 2009,5(2):225. [17] Zhang M, Qian J, Xing X, et a1. Inhibition of the Tumor Necrosis Factor. Alpha Pathway is Radioprotective for the Lung[J]. Clinical Cancer Research, 2008,l4(6):1868. [18] 郑爱青, 韩晨光, 朱新英, 等. IL-1和IL-6在放射性肺损伤发病中的作用[J]. 武警医学院学报, 2009(3):194. [19] Wang C, Abe S, Matsuda K, et a1. Effects of Gefitinib on Radiation-Induced Lung Injury in Mice[J]. Journal of Nippon Medical School, 2008,75(2):96. [20] Thomas D M, Fox J, Haston C K. Imatinib Therapy Reduces Radiation-Induced Pulmonary Mast Cell Influx and Delays Lung Disease in the Mouse[J]. International Journal of Radiation Biology, 2010,86(6):436. [21] Bao P, Gao W, Li S, et a1. Effect of Pretreatment with High-DoseUlinastatin in Preventing Radiation-Induced Pulmonary Injury in Rats[J]. European Journal of Pharmacology, 2009,603(1-3):114. [22] 高秋玲, 庞青松, 王站. 放射性肺炎121例临床分析[J]. 实用癌症杂志,2007,22(1):33. [23] Vasic L, Durdevic P. Radiation-Induced Lung Damage-Etiopathogenesis, Clinical Features, Imaging Findings and Treatment[J]. Medicinski Pregled,2012,65(7-8):319. [24] Kim K, Pollard J M, Norris A J, et a1. High-Throughput ScreeningIdentifies Two Classes of Antibiotics as Radioprotectors: Tetracyclines and Fluoroquinolones[J]. Clinical Cancer Research, 2009,l5(23):7238. [25] 刘艳娥, 王若雨, 李曼. 中西医防治放射性肺损伤的研究[J]. 医师进修杂志, 2001,24(7):56. |